USA CHILDRENS AND WOMENS HOSPITAL — History
CCN 013301 | 3-year financial timeline | COVID resilience: 41/100
🛡️ Public data only — no PHI permitted on this instance.
$229M
Latest Revenue (FY2022)
+6.1%
Revenue CAGR (3yr)
-0.3%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $203M | $210M | $229M | +8.7% | +6.1% |
| Operating Expenses | $173M | $200M | $230M | +14.7% | +15.3% |
| Operating Margin | 15.1% | 4.9% | -0.3% | -106.1% | +0.0% |
| Net Income | $31M | $10M | $-1M | -106.6% | +0.0% |
| Licensed Beds | 249 | 247 | 249 | +0.8% | +0.0% |
| Total Patient Days | 59,937 | 60,235 | 59,374 | -1.4% | -0.5% |
| Medicare Day % | 0% | 0% | 0% | -56.7% | -13.3% |
| Medicaid Day % | 74% | 77% | 75% | -1.6% | +1.0% |
COVID Impact & Recovery
Resilience Score: 41/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +12.5% ($203M → $229M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+6.1%
This Hospital
+7.6%
State Avg
Latest Margin
-0.3%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $242M | -8.0% |
| FY2024 (proj) | $254M | -15.7% |
| FY2025 (proj) | $267M | -23.4% |